Deep Genomics raises US$13 million to fund expansion

Deep Genomics, part of the 2015 UTEST cohort, has raised US$13 million from Khosla Ventures. Deep Genomics combines artificial intelligence and genomics research to help develop genetic medicines to treat a myriad of disorders – everything from autism to cancer. Brendan Frey, CEO and a professor in U of T’s Faculty of Applied Science & Engineering, told the Globe… Read more »

Ardra Bio receives investment from Ontario Genomics

Ontario Genomics invests in renewable chemicals – Ontario Genomics Ontario Genomics is pleased to announce its investment in Ardra Inc. via its Pre-Commercial Business Development Fund. Ardra is a specialty chemicals company focused on the production of natural ingredients for the cosmetics and flavour and fragrance industries. Their synthetic biology platform uses designer biochemical pathways… Read more »

Blue J Legal Focus of Globe & Mail Article – “Artificial intelligence takes the drudgery out of legal work”

Artificial intelligence takes the drudgery out of legal work For years, budding airplane pilots and race-car drivers have been able to strap themselves into virtual simulators to test their respective skills and odds of real-world success. But what about lawyers? Recent advances in artificial intelligence and machine learning mean legal professionals are now getting the… Read more »

UTEST companies move into new entrepreneurship space – ONRamp!

One of the biggest challenges Albert Tai faced when launching a startup was finding the space to do it. The co-founder of Hypercare, a UTEST company from the 2015 cohort, a communication and collaboration app for doctors, recalls bouncing from classroom to coffee shop at the University of Toronto as he and his team looked for places to… Read more »

Dalriada Therapeutics Wins RBC Innovation & Entrepreneurship $25K Grand Prize!

Congratulations to Dalriada Therapeutics for winning the inaugural RBC Innovation & Entrepreneurship Prize! CEO Diana Kraskouskaya did a tremendous job telling the Dalriada story and walked away with $25K in prize money. Full event details found here Pictured above: Professor Cynthia Goh, Gabriel Woo, RBC’s vice-president of innovation,  Dalriada CEO, Diana Kraskouskaya and CSO, Professor Patrick Gunning.

UTEST companies are 4 of 6 finalists for RBC Prize for Innovation!

UT Entrepreneurship announced their top 6 finalists for the RBC Prize for Innovation. UTEST will be represented by: Dalriada Therapeutics is developing a unique ‘cloaking’ therapeutic technology for the treatment of most aggressive, currently untreatable cancers including acute myeloid leukaemia, glioblastoma and medulloblastoma. Dash MD is a mobile patient experience platform that improves recovery outcomes by… Read more »